Systemic lupus erythematosus and familial Mediterranean fever: A possible negative association between the two disease entities - Report of four cases and review of the literature

Lupus

Volumn 17, Issue 7, 2008, Pages 663-669

  Lidar, M ^a,d   Zandman Goddard, G ^b,c   Shinar, Y ^a   Zaks, N ^a   Livneh, A ^a   Langevitz, P ^a  

^a HELLER INSTITUTE OF MEDICAL RESEARCH   (Israel)

^b WOLFSON MEDICAL CENTER   (Israel)

^c SMC   (Israel)

^d SHEBA MEDICAL CENTER   (Israel)

Author keywords

Colchicine; FMF; Systemic lupus erythematosus

Indexed keywords

ACETYLSALICYLIC ACID; AMYLOID; AZATHIOPRINE; COLCHICINE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYCHLOROQUINE; LOW MOLECULAR WEIGHT HEPARIN; PREDNISONE; PROTEIN;

ADULT; ANAMNESIS; ANEMIA; ARTICLE; BIOPSY TECHNIQUE; BLOOD CHEMISTRY; BLOOD CULTURE; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; CREATININE BLOOD LEVEL; DIARRHEA; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; INFLAMMATION; KIDNEY FUNCTION; KIKUCHI DISEASE; LABORATORY TEST; LEUKOPENIA; LOW DRUG DOSE; MYOPATHY; POLYARTHRITIS; PRENATAL CARE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; SEROLOGY; SIDE EFFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY; TREATMENT RESPONSE; UREA NITROGEN BLOOD LEVEL; URINALYSIS;

ADOLESCENT; ADULT; CHILD; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; JEWS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PREGNANCY; REVIEW LITERATURE AS TOPIC; SEROSITIS;

EID: 48249129162     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203308089403     Document Type: Article

References (41)

1. Gaubitz, M. Epidemiology of connective tissue disorders. Rheumatology (Oxford) 2006; 45(Suppl. 3): iii3-iii4.
2. Tan, EM, Cohen, AS, Fries, JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
3. Sohar, E, Gafni, J, Pras, M, Heller, H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 1967; 43: 227-253.
4. Kogan, A, Shinar, Y, Lidar, M, et al. Common MEFV mutations among Jewish ethnic groups in israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state. Am J Med Genet 2001; 102: 272-276.
5. Fidder, H, Chowers, Y, Ackerman, Z, et al. The familial Mediterranean fever (MEVF) gene as a modifier of crohn's disease. Am J Gastroenterol 2005; 100: 338-343.
6. Balaban, B, Yasar, E, Ozgul, A, Dincer, K, Kalyon, TA. Sacroiliitis in familial Mediterranean fever and seronegative spondyloarthropathy: importance of differential diagnosis. Rheumatol Int 2005; 25: 641-644.
7. Langevitz, P, Livneh, A, Zemer, D, Shemer, J, Pras, M. Seronegative spondyloarthropathy in familial Mediterranean fever. Semin Arthritis Rheum 1997; 27: 67-72.
8. Schwartz, T, Langevitz, P, Zemer, D, Gazit, E, Pras, M, Livneh, A. Behcet's disease in familial Mediterranean fever: characterization of the association between the two diseases. Semin Arthritis Rheum 2000; 29: 286-295.
9. Schlesinger, M, Rubinow, A, Vardy, PA. Henoch-schonlein purpura and familial Mediterranean fever. Isr J Med Sci 1985; 21: 83-85.
10. Gur, H, Tchakmakjian, L, Eherenfeld, M, Sidi, Y. Polyarteritis nodosa: a report from israel. Am J Med Sci 1999; 317: 238-242.
11. Glikson, M, Galun, E, Schlesinger, M, et al. Polyarteritis nodosa and familial Mediterranean fever: a report of 2 cases and review of the literature. J Rheumatol 1989; 16: 536-539.
12. Langevitz, P, Zemer, D, Livneh, A, Shemer, J, Pras, M. Protracted febrile myalgia in patients with familial Mediterranean fever. J Rheumatol 1994; 21: 1708-1709.
13. Rabinovich, E, Livneh, A, Langevitz, P, et al. Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene. Ann Rheum Dis 2005; 64: 1009-1014.
14. Rozenbaum, M, Rosner, I. Severe outcome of juvenile idiopathic arthritis (JIA) associated with familial Mediterranean fever (FMF). Clin Exp Rheumatol 2004; 22: S75-S78.
15. Atagunduz, P, Ergun, T, Direskeneli, H. MEFV mutations are increased in behcet's disease (BD) and are associated with vascular involvement. Clin Exp Rheumatol 2003; 21: S35-S37.
16. Shinar, Y, Livneh, A, Villa, Y, et al. Common mutations in the familial Mediterranean fever gene associate with rapid progression to disability in non-ashkenazi Jewish multiple sclerosis patients. Genes Immun 2003; 4: 197-203.
17. Ayvazyan, A. Systemic lupus erythematosus, polyarteritis nodosa and familial Mediterranean fever in armenia. Ann Rheum Dis 2006; 65: 255.
18. Bakir, F, Saaed, B. Systemic lupus erythematosus and periodic peritonitis (FMF). Br J Rheumatol 1989; 28: 81-82.
19. Langevitz, P, Livneh, A, Zemer, D, Dolitzky, M, Pras, M. Systemic lupus erythematosus in patients with familial Mediterranean fever. Lupus 1995; 4: 11.
20. Pauzner, R, Dulitzki, M, Langevitz, P, Livneh, A, Kenett, R, Many, A. Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy. Thromb Haemost 2001; 86: 1379-1384.
21. Lim, KL, Abdul-Wahab, R, Lowe, J, Powell, RJ. Muscle biopsy abnormalities in systemic lupus erythematosus: correlation with clinical and laboratory parameters. Ann Rheum Dis 1994; 53: 178-182.
22. Livneh, A, Langevitz, P, Zemer, D, et al. The changing face of familial Mediterranean fever. Semin Arthritis Rheum 1996; 26: 612-627.
23. Zandman-Goddard, G, Blank, M, Langevitz, P, et al. Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity. Ann Rheum Dis 2005; 64: 1698-1702.
24. Lidar, M, Kedem, R, Mor, A, Levartovsky, D, Langevitz, P, Livneh, A. Arthritis as the sole episodic manifestation of familial Mediterranean fever. J Rheumatol 2005; 32: 859-862.
25. Cronin, ME. Musculoskeletal manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am 1988; 14: 99-116.
26. Cervera, R, Khamashta, MA, Font, J, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The european working party on systemic lupus erythematosus. Medicine (Baltimore) 1993; 72: 113-124.
27. Ben-Chetrit, E. Familial Mediterranean fever (FMF) and renal AA amyloidosis - phenotype-genotype correlation, treatment and prognosis. J Nephrol 2003; 16: 431-434.
28. Dixon, AJ, Wall, GC. Probable colchicine-induced neutropenia not related to intentional overdose. Ann Pharmacother 2001; 35: 192-195.
29. Turkmen, MSA, Kavukcu, S. Familial Mediterranean fever with atypical onset. Clin Exp Rheumatol 2002; 20: 100.
30. Lachmann, HJ, Sengul, B, Yavuzsen, TU, et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 2006; 45: 746-750.
31. Emsley, J, White, HE, O'Hara, BP, et al. Structure of pentameric human serum amyloid P component. Nature 1994; 367: 338-345.
32. Gillmore, JD, Hutchinson, WL, Herbert, J, et al. Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination? Immunology 2004; 112: 255-264.
33. Lidar, MDA, Kedem, R, Yosepovich, A, Langevitz, P, Livneh, A. Appendectomy in familial Mediterranean fever: clinical, genetic and pathological findings. Clin Exp Rheum 2007; 2008, accepted.
34. Ozen, S, Bakkaloglu, A, et al. C reactive protein: protecting from lupus in familial Mediterranean fever. Ann Rheum Dis 2005; 64: 786-787.
35. Lachmann, HJ, Sengul, B, Yavuzsen, TU, et al. Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 2006; 45: 746-750.
36. Suh, CH, Chun, HY, Ye, YM, Park, HS. Unresponsiveness of C-reactive protein in the non-infectious inflammation of systemic lupus erythematosus is associated with interleukin 6. Clin Immunol 2006; 119: 291-296.
37. Spronk, PE, Limburg, PC, Kallenberg, CG. Serological markers of disease activity in systemic lupus erythematosus. Lupus 1995; 4: 86-94.
38. Bijl, M, Bootsma, H, Van Der Geld, Y, Limburg, PC, Kallenberg, CG, Van Rijswijk, MH. Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction. Ann Rheum Dis 2004; 63: 831-835.
39. Abu-Shakra, M, Lorber, M, Neumann, L, Buskila, D. Features of SLE in various ethnic groups in israel. Clin Exp Rheumatol 1997; 15: 181-184.
40. Wysenbeek, AJ, Leibovici, L, Weinberger, A, Guedj, D. Expression of systemic lupus erythematosus in various ethnic Jewish israeli groups. Ann Rheum Dis 1993; 52: 268-271.
41. Ben-Chetrit, E, Levy, M. Colchicine: 1998 update. Semin Arthritis Rheum 1998; 28: 48-59.